A randomized, placebo-controlled, double blind, multicenter, phase IIa study of AZD-9056 in adult patients with moderately to severely active Crohn's-disease
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2016
At a glance
- Drugs AZD 9056 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 21 Jul 2016 New trial record.